| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.0048 | 1 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |